Chin-Yu Lai

603 total citations
20 papers, 523 citations indexed

About

Chin-Yu Lai is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Chin-Yu Lai has authored 20 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Chin-Yu Lai's work include Synthesis of Organic Compounds (5 papers), Synthesis and biological activity (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Chin-Yu Lai is often cited by papers focused on Synthesis of Organic Compounds (5 papers), Synthesis and biological activity (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Chin-Yu Lai collaborates with scholars based in Taiwan, United States and China. Chin-Yu Lai's co-authors include Kuo‐Hsiung Lee, Kenneth F. Bastow, Susan L. Morris‐Natschke, Che‐Ming Teng, Kyoko Nakagawa‐Goto, Shiow‐Lin Pan, Yizhou Dong, Tian-Shung Wu, An‐Chi Tsai and Pei-Chi Wu and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and American Journal Of Pathology.

In The Last Decade

Chin-Yu Lai

20 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chin-Yu Lai Taiwan 14 247 231 112 91 53 20 523
Tian Wu China 13 288 1.2× 190 0.8× 89 0.8× 57 0.6× 46 0.9× 24 585
Asif Khurshid Qazi India 16 319 1.3× 137 0.6× 61 0.5× 92 1.0× 45 0.8× 20 527
Laetitia Moreno Y Banuls Belgium 12 224 0.9× 140 0.6× 109 1.0× 93 1.0× 27 0.5× 18 465
Po-Cheng Chiang Taiwan 10 227 0.9× 126 0.5× 84 0.8× 68 0.7× 41 0.8× 11 490
Yu-Hsuan Lan Taiwan 17 356 1.4× 138 0.6× 86 0.8× 134 1.5× 50 0.9× 22 688
Sandeep Jain India 14 230 0.9× 134 0.6× 99 0.9× 60 0.7× 146 2.8× 29 562
Yi Li Wong Malaysia 13 227 0.9× 116 0.5× 101 0.9× 61 0.7× 108 2.0× 20 582
Chatchakorn Eurtivong Thailand 15 224 0.9× 187 0.8× 65 0.6× 41 0.5× 43 0.8× 41 468
Gangqiang Wang China 17 232 0.9× 425 1.8× 175 1.6× 66 0.7× 25 0.5× 60 748
François Gaascht Luxembourg 13 298 1.2× 122 0.5× 217 1.9× 90 1.0× 30 0.6× 14 623

Countries citing papers authored by Chin-Yu Lai

Since Specialization
Citations

This map shows the geographic impact of Chin-Yu Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin-Yu Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin-Yu Lai more than expected).

Fields of papers citing papers by Chin-Yu Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin-Yu Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin-Yu Lai. The network helps show where Chin-Yu Lai may publish in the future.

Co-authorship network of co-authors of Chin-Yu Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Chin-Yu Lai. A scholar is included among the top collaborators of Chin-Yu Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin-Yu Lai. Chin-Yu Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chao, Min‐Wu, Li‐Ting Wang, Chin-Yu Lai, et al.. (2015). eIF4E binding protein 1 expression is associated with clinical survival outcomes in colorectal cancer. Oncotarget. 6(27). 24092–24104. 20 indexed citations
2.
Pan, Shiow‐Lin, et al.. (2013). Activated PAR-2 Regulates Pancreatic Cancer Progression through ILK/HIF-α–Induced TGF-α Expression and MEK/VEGF-A–Mediated Angiogenesis. American Journal Of Pathology. 183(2). 566–575. 40 indexed citations
3.
He, Xiaoyang, Chunping Gu, Emika Ohkoshi, et al.. (2013). Discovery of novel antitumor dibenzocyclooctatetraene derivatives and related biphenyls as potent inhibitors of NF-κB signaling pathway. Bioorganic & Medicinal Chemistry. 22(1). 325–333. 5 indexed citations
4.
Lai, Chin-Yu, Shiow‐Lin Pan, Ya-Ling Chang, et al.. (2013). Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects. Carcinogenesis. 34(9). 2050–2060. 9 indexed citations
5.
Shen, De-Yang, Chih‐Hua Chao, Hsiu-Hui Chan, et al.. (2012). Bioactive constituents of Clausena lansium and a method for discrimination of aldose enantiomers. Phytochemistry. 82. 110–117. 47 indexed citations
6.
Lai, Chin-Yu, An‐Chi Tsai, Mei-Chuan Chen, et al.. (2012). Aciculatin Induces p53-Dependent Apoptosis via MDM2 Depletion in Human Cancer Cells In Vitro and In Vivo. PLoS ONE. 7(8). e42192–e42192. 40 indexed citations
7.
Yang, Xiaoming, Qian Shi, Chin-Yu Lai, et al.. (2012). Antitumor Agents 295. E-Ring Hydroxylated Antofine and Cryptopleurine Analogues as Antiproliferative Agents: Design, Synthesis, and Mechanistic Studies. Journal of Medicinal Chemistry. 55(15). 6751–6761. 22 indexed citations
8.
9.
Dong, Yizhou, Kyoko Nakagawa‐Goto, Chin-Yu Lai, et al.. (2011). Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity. Bioorganic & Medicinal Chemistry Letters. 21(8). 2341–2344. 31 indexed citations
10.
Yang, Xiaoming, Qian Shi, Shuenn-Chen Yang, et al.. (2011). Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues as Potent and Selective Antitumor Agents. Journal of Medicinal Chemistry. 54(14). 5097–5107. 34 indexed citations
11.
Rosselli, Sergio, Maurizio Bruno, Antonella Maggio, et al.. (2011). Cytotoxic geranylflavonoids from Bonannia graeca. Phytochemistry. 72(9). 942–945. 10 indexed citations
12.
Yang, Mei-Lin, Ping‐Chung Kuo, Tsong‐Long Hwang, et al.. (2011). Synthesis, in vitro anti-inflammatory and cytotoxic evaluation, and mechanism of action studies of 1-benzoyl-β-carboline and 1-benzoyl-3-carboxy-β-carboline derivatives. Bioorganic & Medicinal Chemistry. 19(5). 1674–1682. 42 indexed citations
13.
Chen, Ying, Hongrui Liu, Ming Cheng, et al.. (2011). Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents. European Journal of Medicinal Chemistry. 49. 74–85. 67 indexed citations
14.
Nakagawa‐Goto, Kyoko, Pei-Chi Wu, Chin-Yu Lai, et al.. (2011). Antitumor Agents. 284. New Desmosdumotin B Analogues with Bicyclic B-Ring as Cytotoxic and Antitubulin Agents. Journal of Medicinal Chemistry. 54(5). 1244–1255. 26 indexed citations
15.
Tsai, An‐Chi, Shiow‐Lin Pan, Chin-Yu Lai, et al.. (2010). The inhibition of angiogenesis and tumor growth by denbinobin is associated with the blocking of insulin-like growth factor-1 receptor signaling. The Journal of Nutritional Biochemistry. 22(7). 625–633. 12 indexed citations
16.
Kozaka, Takashi, Kyoko Nakagawa‐Goto, Qian Shi, et al.. (2010). Antitumor agents 273. Design and synthesis of N-alkyl-thiocolchicinoids as potential antitumor agents. Bioorganic & Medicinal Chemistry Letters. 20(14). 4091–4094. 18 indexed citations
17.
Dong, Yizhou, Kyoko Nakagawa‐Goto, Chin-Yu Lai, et al.. (2010). Antitumor agents 279. Structure–activity relationship and in vivo studies of novel 2-(furan-2-yl)naphthalen-1-ol (FNO) analogs as potent and selective anti-breast cancer agents. Bioorganic & Medicinal Chemistry Letters. 21(1). 52–57. 12 indexed citations
18.
Nakagawa‐Goto, Kyoko, Po‐Cheng Chang, Chin-Yu Lai, et al.. (2010). Antitumor Agents. 280. Multidrug Resistance-Selective Desmosdumotin B Analogues. Journal of Medicinal Chemistry. 53(18). 6699–6705. 20 indexed citations
19.
Dong, Yizhou, Kyoko Nakagawa‐Goto, Chin-Yu Lai, et al.. (2010). Antitumor agents 278. 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 20(14). 4085–4087. 40 indexed citations
20.
Usami, Yoshihide, Kyoko Nakagawa‐Goto, Jing-Yu Lang, et al.. (2010). Antitumor Agents. 282. 2′-(R)-O-Acetylglaucarubinone, a Quassinoid fromOdyendyea gabonensisAs a Potential Anti-Breast and Anti-Ovarian Cancer Agent. Journal of Natural Products. 73(9). 1553–1558. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tian Wu Breakdown of academic impact, for papers by Asif Khurshid Qazi Breakdown of academic impact, for papers by Laetitia Moreno Y Banuls Breakdown of academic impact, for papers by Po-Cheng Chiang Breakdown of academic impact, for papers by Yu-Hsuan Lan Breakdown of academic impact, for papers by Sandeep Jain Breakdown of academic impact, for papers by Yi Li Wong Breakdown of academic impact, for papers by Chatchakorn Eurtivong Breakdown of academic impact, for papers by Gangqiang Wang Breakdown of academic impact, for papers by François Gaascht
Rankless by CCL
2026